Iris Melanoma
📧 Sign up to get email alerts when something new happens for Iris Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma [Phase 1]
Phase 1 trial update reports proof of concept for TBio-4101 in combination with lymphodepleting chemotherapy and IL-2 for relapsed/refractor…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]
A Phase 2 clinical trial evaluating temozolomide or selumetinib for metastatic melanoma of the eye (uveal/iris melanoma) has completed, with…
-
CLINICAL_TRIALS trial_result · 2015-07-20Clinical Trial Update: Cixutumumab in Treating Patients With Metastatic Melanoma of the Eye [Phase 2]
Phase 2 trial update for cixutumumab in metastatic intraocular melanoma (ciliary body/choroid, iris) completed with posted results in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: AZD2171 in Treating Patients With Recurrent or Stage IV Melanoma [Phase 2]
A Phase 2 trial evaluating AZD2171 for recurrent or Stage IV melanoma has completed enrollment with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2014-05-22Clinical Trial Update: Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma [Phase 2]
A Phase 2 vaccine therapy trial in melanoma patients with Stage IIC to IV disease has completed. The trial encompassed intraocular subtypes …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-05Clinical Trial Update: Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of bortezomib, paclitaxel, and carboplatin in patients with metastatic and intraocular melanoma h…
-
CLINICAL_TRIALS trial_result · 2012-07-11Clinical Trial Update: Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye [Phase 2]
Phase 2 trial evaluating sorafenib in combination with carboplatin and paclitaxel for stage IV ocular melanoma has completed enrollment, wit…